New Risk • May 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 61% per year over the past 5 years. Shareholders have been substantially diluted in the past year (142% increase in shares outstanding). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end). Announcement • Mar 04
IPAS Indexo AS, Annual General Meeting, Mar 24, 2026 IPAS Indexo AS, Annual General Meeting, Mar 24, 2026, at 16:00 FLE Standard Time. Location: ac hotel riga, 33 dzirnavu street, riga, lv 1010, 11th floor, Latvia New Risk • Dec 22
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 61% per year over the past 5 years. Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). 
